Physician profile
Hasan Badday
NPI 1225293095
$6,150.23
in general payments reported to CMS, 2019-2025
38 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $226 · 2021: $1,237 · 2022: $1,581 · 2023: $861 · 2024: $1,091 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266 · Travel and Lodging: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,266.05 |
| Travel and Lodging | $891.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,247.40 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $988.24 | 2022-2023 | Intracept |
| Stryker Corporation | $863.59 | 2019-2024 | Spinejack |
| Nevro Corp. | $777.70 | 2019-2023 | Senza |
| Forte Bio-Pharma LLC | $500.34 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $175.59 | 2019-2024 | Belbuca |
| Daiichi Sankyo INC. | $169.05 | 2019 | |
| Si-Bone, INC. | $118.56 | 2020-2025 | |
| Electronic Waveform Lab, INC. | $106.35 | 2019-2022 | |
| Abbott Laboratories | $101.23 | 2019-2025 | Eterna |
| Bausch Health US, LLC | $100.84 | 2019-2020 | |
| Depuy Synthes Sales INC. | $99.74 | 2019-2025 | Orthovisc, Monovisc |
| Merz North America, INC. | $89.05 | 2021 | |
| Stimwave Technologies Incorporated | $82.90 | 2019-2022 | |
| Curonix LLC | $64.58 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $61.79 | 2019 | |
| Bioventus LLC | $58.11 | 2019-2023 | Supartz Fx Sodium Hyaluronate, Durolane |
| Vertos Medical, INC. | $57.44 | 2022-2024 | Mild Device Kit |
| Allergan, INC. | $56.99 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $54.29 | 2019-2023 | Ztlido |
| Globus Medical, INC. | $34.73 | 2025 | Senza |
| Tenex Health INC. | $33.06 | 2020 | |
| Stratus Medical, LLC | $30.54 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $30.29 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $23.27 | 2019 | |
| Fidia Pharma USA INC. | $23.12 | 2019 | |
| Azurity Pharmaceuticals, INC. | $22.76 | 2024 | Horizant |
| Medtronic USA, INC. | $22.45 | 2020 | |
| Neuronetics, INC. | $20.57 | 2024 | Neurostar Tms Therapy System |
| West Therapeutics Development, LLC | $18.30 | 2020 | |
| Pfizer INC. | $17.91 | 2019 | |
| Abbvie INC. | $16.65 | 2022 | |
| Spr Therapeutics, INC | $16.13 | 2023 | Sprint Pns System |
| Medtronic, INC. | $15.74 | 2021 | |
| Orthogenrx INC. | $14.04 | 2020 | |
| Biotissue Holdings INC. | $13.00 | 2022 | |
| Assertio Therapeutics, INC. | $12.49 | 2019 | |
| Vertiflex, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Badday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.